CrushSCI.com
提供学术论文选刊润色服务
BONE MARROW TRANSPLANTATION 临时占位封面 医学
返回期刊列表

Review Cycle Records

BONE MARROW TRANSPLANTATION

Springer SCIE 非OA
2026新锐 2区2025中科院 2区2025 JCR Q1
128.2平均天数
127中位天数
24最短天数
219最长天数
2892025发文量

Paper Review Records

全部论文审稿周期

5 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

219 天

Pregnancy outcomes in women conceiving after hematopoietic stem cell transplantation versus conventional chemotherapy for childhood or adolescent acute leukemia

作者Loïc Guillerault; Paul Saultier; Carine Domenech; Stéphane Ducassou; Virginie Gandemer; Sandrine Visentin; Cécile Renard; Catherine Paillard; Marilyne Poiree; Aurélie Phulpin; Justyna Kanold; Marie-Dominique Tabone; Jean-Hugues Dalle; Laura Olivier; Corinne Armari-Alla; Sandrine Thouvenin; Isabelle Pellier; Pascal Auquier; Julie Berbis; Gérard Michel; Blandine Courbiere

作者单位1. Department of Gynecology-Obstetric and Reproductive Medicine, AP-HM, Hôpital La Conception, Marseille, France; 2. Department of Pediatric Hematology, Immunology and Oncology, Aix Marseille Univ, APHM, INSERM, INRAe, C2VN, La Timone Children’s Hospital, Marseille, France; 3. Department of Pediatric Hematology and Oncology, IHOP, Hospices Civils de Lyon, Lyon 1 University, Lyon, France; 4. Department of Pediatric Hematology and Oncology, University Hospital of Bordeaux, Bordeaux, France; 5. Department of Pediatric Hematology and Oncology, University Hospital of Rennes, Rennes, France; 6. Department of Pediatric Hematology, Immunology and Oncology, APHM, La Timone Children’s Hospital, Marseille, France; 7. Department of Pediatric Hematology-Oncology, University Hospital, Strasbourg, France; 8. Department of Pediatric Hematology and Oncology, University Hospital L’Archet, Nice, France; 9. Department of Pediatric Hematology and Oncology, Children’s Hospital of Brabois, Vandoeuvre-Les-Nancy, France; 10. Department of Pediatric Hematology and Oncology, CIC Inserm 501, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France; 11. Department of Pediatric Hematology, Immunology and Oncology, Hôpital Armand Trousseau, Paris, France; 12. Department of Hematology and immunology, Hôpital Robert-Debré, GHU APHP-Nord Université Paris-Cité, Paris, France; 13. Department of Pediatric Hematology and Oncology, University Hospital of Toulouse, Toulouse, France; 14. Department of Pediatric Hematology-Oncology, University Hospital of Grenoble, Grenoble, France; 15. Department of Pediatric Onco-hematology, University Hospital of Saint-Etienne, Saint-Etienne, France; 16. Department of Pediatric Hematology, Immunology and Oncology, University Hospital of Angers, Angers, France; 17. Department of Epidemiology and Health Economics, Aix Marseille Univ, APHM, CEReSS, Health Service Research and Quality of Life Center, Equipe labellisée Ligue contre le Cancer, La Timone Hospital, Marseille, France; 18. CEReS Research Unit EA 3279 and Department of Public Health, Hôpital de la Timone, Marseille, France; 19. IMBE, Aix Marseille Univ, Avignon Univ, CNRS, IRD, Marseille, France

PDF源文件 DOI 网页
127 天

Real-world experience with posttransplant maintenance therapy in patients with myeloid neoplasms with active disease before allogeneic hematopoietic cell transplantation

作者Hüseyin Sakiz; Raphael Battegay; Beatrice Drexler; Darius Juskevicius; Sabine Gerull; Michele Hoffmann; Roby Mathew; Francesca Matteazzi; Lucas Simeon; Georg Stussi; Jakob R. Passweg; Joerg P. Halter

作者单位1. Department of Hematology, University Hospital Basel, Basel, Switzerland; 2. Department of Hematology, Cantonal Hospital Aarau, Aarau, Switzerland; 3. Department of Medical Oncology, Inselspital, University Hospital of Bern, Bern, Switzerland; 4. Department of Hematology, Luzerner Kantonsspital, Lucerne, Switzerland; 5. Clinic of Hematology, Oncology Institute of Southern Switzerland, Bellinzona, Switzerland

PDF源文件 DOI 网页
154 天

Mycophenolate mofetil-based graft-versus-host disease prophylaxis is associated with an increased risk of human herpesvirus 6B encephalitis after cord blood transplantation

作者Takuto Mori; Nobuhiro Hiramoto; Yoshimitsu Shimomura; Masao Ogata; Kaito Harada; Naoyuki Uchida; Masatsugu Tanaka; Makoto Onizuka; Masahito Tokunaga; Atsushi Wake; Yasufumi Uehara; Toshimitsu Ueki; Masashi Sawa; Satoshi Takahashi; Mamiko Sakata-Yanagimoto; Keisuke Kataoka; Toshiro Kawakita; Noriko Doki; Fumihiko Ishimaru; Junya Kanda; Takahiro Fukuda; Yoshiko Atsuta; Hideki Nakasone; Kimikazu Yakushijin

作者单位1. Division of Cancer Evolution, National Cancer Center Research Institute, Tokyo, Japan; 2. Department of Hematology, Graduate School of Medicine, Kyoto University, Kyoto, Japan; 3. Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan; 4. Department of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Suita, Japan; 5. Department of Medical Oncology and Hematology, Oita University Faculty of Medicine, Oita, Japan; 6. Department of Hematology/Oncology, Tokai University School of Medicine, Isehara, Japan; 7. Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations Toranomon Hospital, Tokyo, Japan; 8. Department of Hematology, Kanagawa Cancer Center, Yokohama, Japan; 9. Department of Hematology, Imamura General Hospital, Kagoshima, Japan; 10. Department of Hematology, Federation of National Public Service Personnel Mutual Aid Associations, Toranomon Hospital, Kawasaki, Japan; 11. Department of Hematology, Kitakyushu City Hospital Organization, Kitakyushu Municipal Medical Center, Kitakyushu, Japan; 12. Department of Hematology, Nagano Red Cross Hospital, Nagano, Japan; 13. Department of Hematology and Oncology, Anjo Kosei Hospital, Anjo, Japan; 14. Department of Hematology/Oncology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan; 15. Department of Hematology, University of Tsukuba Hospital, Tsukuba, Japan; 16. Division of Hematology, Department of Medicine, Keio University School of Medicine, Tokyo, Japan; 17. Department of Hematology, NHO Kumamoto Medical Center, Kumamoto, Japan; 18. Hematology Division, Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital, Tokyo, Japan; 19. Japanese Red Cross Blood Service Headquarters, Tokyo, Japan; 20. Department of Hematopoietic Stem Cell Transplantation, National Cancer Center Hospital, Tokyo, Japan; 21. Japanese Data Center for Hematopoietic Cell Transplantation, Nagakute, Japan; 22. Department of Registry Science for Transplant and Cellular Therapy, Aichi Medical University School of Medicine, Nagakute, Japan; 23. Division of Emerging Medicine for Integrated Therapeutics (EMIT), Center for Molecular Medicine, Jichi Medical University, Shimotsuke, Japan; 24. Division of Hematology, Jichi Medical University Saitama Medical Center, Saitama, Japan; 25. Department of Medical Oncology and Hematology, Kobe University Hospital, Kobe, Japan

PDF源文件 DOI 网页
117 天

Use of an unrelated cord blood unit as an emergency rescue graft after last-minute donor collection cancellation

作者Irene Donnini; Sergio Querol; Nerea Castillo; Simona Pollichieni; Chiara Nozzoli; Alejandra Martínez-Trillos; Mónica Linares; Michela Santosuosso; Serena Urbani; Jesús Fernández-Sojo; Nicoletta Sacchi

作者单位1. Cell Therapy and Transfusion Medicine Unit, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy; 2. Spanish Bone Marrow Donor Registry (REDMO), Josep Carreras Leukaemia Foundation, Barcelona, Spain; 3. Cell Therapy Service and Barcelona Cord Blood Bank, Banc de Sang i Teixits, Barcelona, Spain; 4. Italian Bone Marrow Donor Registry (IBMDR), Diagnostic and Therapeutic Services Department, E.O. Ospedali Galliera, Genoa, Italy; 5. Hematology Department, Azienda Ospedaliero-Universitaria Careggi, Florence, Italy

PDF源文件 DOI 网页
24 天

PTCy-based GVHD prophylaxis helps navigate donor selection in secondary AML undergoing alternative donor transplantation

作者Punit Jain

作者单位1. Department of Hematology & Bone Marrow Transplant, Apollo Hospitals, Navi Mumbai, India

PDF源文件 DOI 网页

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿96.4 天

中位数77 天

Contact CrushSCI

联系 CrushSCI

扫码添加微信,或留下手机号/微信号,我们将与你确认稿件阶段、编辑需求和投稿计划。

当前选择:论文编辑服务

也可以预留联系方式

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。